A hope &a dream---the beauty of spec biotechs. It may work out, it may not---why it's a $3-4 stock. Management hasn't done anything in the last 12-13 years so you can't bet on them. Sellick spends all him time out on the road trying to tell his story ...... not too successful.
come on now rookie---be nice. you've been predicting great things from this spec mgmt. team for the last 3 years. just because there are other small retail spec players playing the lottery dream doesn't
mean you have to get all tight in your shorts & become so #$%$. Does mommie still have a job
There are TWO imminent approvals right now at the FDA----Strensiq AND Kanuma. Both have $billion dollar sales$ potential --- and fit in nicely with a 50 nation sales force already primed & trained to go. Unless the world comes to an end in the 4Q I would say that ALXN can be approaching $200 area by year-end. People who know & follow biotech full-time recognize that you don't often get the chance to buy a company growing at 25%+ top & bottom line at a discount to its growth rate with new product sales any day now. This stock is not owned by retail.
There are many many reasons why ALXN has been one of the very top growth stocks ove the last decade & will continue to d so. Dig into the story a little more closely before your puts expire.
People speculating on SHPY having RDUS on their radar if they walk away from BXLT offer. RDUS is a nice story on its own but an offer gets the stock to the $90 or better area IMO.
Beachball is never in doubt & never right. THLD puts out press releases on all data that they can. THLD is doing whatever they a can to get attention----you don't see any professional filings of note on the stock. Also, hiring ONE guy is hardly ground moving.
now leave the beachball alone !! so what if her & the other penny stock speculators haven't been accurate on their "forecasts". When you play in the micro-cap spec space you are playing lottery tickets & why not THLD ??? CEO Sellick has been a loser for the last 13 years----maybe his luck is about to turn. The retail bulls are allowed to hope----as noted 2 years ago the institutional biotech investors will not invest until THLD can get over the goal line. anything is possible but THLD & mgmt. has been far from able to deliver.
4.82 ????? is little beachball staring to puff out her chest once again ???? hysterical !!! keep the comedy coming ! is Dendreon still bankrupt ????? you funneeee !!
no you haven't !!! this is a winner will be a winner as long as you believe ! forget the science ! TTPH has $6 in cash that will take over a year to deplete.
yes --- take out another mortgage & buy call. see if you can also borrow from friends & family.
Oh you did not realize ? maybe we can get a research report or two to help little people like yourself. would that help you little Stanley ?
Comforting ??? THLD is a microcap spec which puts it in the highly speculative camp. There are hundreds of small cap biotechs like this hoping for their day in the sun---its not an operating revenue & earnings story.